Literature
首页医源资料库在线期刊美国临床营养学杂志2005年82卷第3期

Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation

来源:《美国临床营养学杂志》
摘要:Objective:Thepurposeofthisstudywastoevaluatetheassociationbetweenserumconcentrationsof25-hydroxyvitaminD[25(OH)D]andgingivalinflammation。1,25-DihydroxyvitaminD3[1,25(OH)2D3]wasshowntoinhibitantigen-inducedTcellproliferationandcytokineproduction(1,2)。Inepide......

点击显示 收起

Thomas Dietrich, Martha Nunn, Bess Dawson-Hughes and Heike A Bischoff-Ferrari

1 From the Department of Health Policy and Health Services Research, Boston University Goldman School of Dental Medicine, Boston, MA (TD and MN); the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (BD-H); and the Divisions of Aging and Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA (HAB-F)

2 Supported by grants K24 DE00419 and U54 DE14264 from the National Institutes of Health.

3 Reprints not available. Address correspondence to T Dietrich, Department of Health Policy and Health Services Research, Department of Periodontology and Oral Biology, Boston University Goldman School of Dental Medicine, 715 Albany Street, 560, Boston, MA 02118. E-mail: tdietric{at}bu.edu


ABSTRACT  
Background: Vitamin D has been shown to have immunomodulatory effects in in vitro and in animal studies. However, data from clinical studies of inflammatory diseases are scarce.

Objective: The purpose of this study was to evaluate the association between serum concentrations of 25-hydroxyvitamin D [25(OH)D] and gingival inflammation.

Design: We analyzed data from 77 503 gingival units (teeth) in 6700 never smokers aged 13 to >90 y from the third National Health and Nutrition Examination Survey. Multiple logistic regression models adjusted for subject- and site-specific covariates included age, sex, race-ethnicity, income, body mass index, diabetes, use of oral contraceptives and hormone replacement therapy among women, intake of vitamin C, missing teeth, full crown coverage, presence of calculus, frequency of dental visits, and dental examiner and survey phase. Generalized estimating equations were used to account for correlated observations within subjects.

Results: Compared with sites in subjects in the lowest 25(OH)D quintile, sites in subjects in the highest 25(OH)D quintile were 20% (95% CI: 8%, 31%) less likely to bleed on gingival probing (P for trend < 0.001). The association appeared to be linear over the entire 25(OH)D range, was consistent across racial or ethnic groups, and was similar among men and women as well as among users and nonusers of vitamin and mineral supplements.

Conclusions: Vitamin D may reduce susceptibility to gingival inflammation through its antiinflammatory effects. Gingivitis may be a useful clinical model to evaluate the antiinflammatory effects of vitamin D.

Key Words: 25-Hydroxyvitamin D • inflammatory disease • gingivitis • periodontal disease


INTRODUCTION  
Vitamin D plays an important role in calcium homeostasis and is essential for bone growth and preservation. More recently, antiinflammatory effects of vitamin D have been described. 1,25-Dihydroxyvitamin D3 [1,25(OH)2D3] was shown to inhibit antigen-induced T cell proliferation and cytokine production (1, 2). In animal studies, beneficial effects of vitamin D and its analogues were found for various autoimmune diseases (3). In epidemiologic studies inverse associations between intake of vitamin D and incidence of multiple sclerosis (4) and type 1 diabetes (5) have been documented. However, evidence for the antiinflammatory effect of vitamin D from clinical studies in humans is scarce (6, 7). Consequently, it is unknown whether vitamin D exerts antiinflammatory effects relevant to human disease. Furthermore, little is known about the range of serum concentrations of 25-hydroxyvitamin D [25(OH)D] that may have antiinflammatory effects in humans.

Some studies have suggested that vitamin D may have beneficial effects on periodontal disease and tooth loss, possibly because of its antiinflammatory effects (8, 9). Another common dental health problem, prevalent across all ages, is chronic marginal gingivitis, a chronic inflammation of the gingival tissues that is induced by bacterial dental plaque. In susceptible patients, this gingival inflammation may eventually lead to the destruction of periodontal ligament and alveolar bone and may thus evolve into periodontal disease. However, the development of marginal gingivitis itself is unrelated to the underlying bone, and any association between vitamin D status and marginal gingivitis must, therefore, be unrelated to the effects of vitamin D on bone. The susceptibility to gingivitis shows considerable interindividual variation and can be readily assessed with the use of an experimental gingivitis model (10, 11). Thus, marginal gingivitis could be a useful model to evaluate specifically the antiinflammatory effects of vitamin D in humans. However, whether 25(OH)D serum concentrations are associated with gingivitis susceptibility has not been investigated.

The purpose of the present study was to evaluate whether an association exists between serum concentrations of 25(OH)D and gingival inflammation in a large sample of the civilian, noninstitutionalized US population [third National Health and Nutrition Examination Survey (NHANES III)] aged 13 to >90 y. If so, we evaluated whether an identifiable threshold concentration exists above which no association can be observed.


SUBJECTS AND METHODS  
Data source
Data were derived from NHANES III, which was conducted between 1988 and 1994 to assess the health and nutrition of a large representative sample of the civilian, noninstitutionalized US population. The survey was designed as a complex, multistage, stratified, clustered sample survey. A detailed description of the survey and the oral health component can be found elsewhere (12). Furthermore, detailed analyses on the periodontal health of the NHANES III population have been previously published (13, 14).

Assessment of 25-hydroxyvitamin D status
Venous blood samples were taken in a standardized fashion. Serum concentrations of 25(OH)D were assayed with a radioimmunoassay kit (Dia-Sorin, Stillwater, MN) (15). The reference range for the assay is 22.5–94 nmol/L and was established in healthy, predominantly white volunteers in the midwestern United States in October, when 25(OH)D concentrations are expected to be lower than those reported in the present study.

Dental assessments
Periodontal indexes were assessed in 2 randomly selected upper and lower quadrants on fully erupted teeth other than wisdom teeth by trained examiners in subjects aged 13 y. For assessment of gingival inflammation, a periodontal probe was inserted 2 mm into the gingival sulcus and then gently moved into the mesial interproximal area. Gingival bleeding on this stimulus (ie, bleeding on probing) was scored as a dichotomous variable at each site (bleeding present or absent). Bleeding from the gingival sulcus on gentle probing with a periodontal probe (bleeding on probing) is a specific symptom of chronic gingivitis and widely used in clinical dental practice and dental research (16). In addition, the examiner recorded calculus (yes or no), probing pocket depth (in mm), clinical attachment level (in mm), full artificial crown coverage (yes or no), and number of teeth. Details of the extensive quality-control and quality-assurance protocol in the oral component of NHANES III, including reliability statistics for selected periodontal indexes, have been published previously (12, 17).

Data on covariates
Participants were administered several structured interviews, both at home and in the mobile examination center. Respondents were classified as never smokers if they had smoked <100 cigarettes in their lifetime. Furthermore, serum cotinine concentrations were determined with the use of an enzyme immunoassay and a liquid chromatography mass spectrometry method (15).

The poverty-to-income ratio was computed as the ratio of family income compared with the poverty threshold as published annually by the Census Bureau. Missing values for the poverty-to-income ratio were coded as missing.

Furthermore, subjects were classified according to any use of multivitamin and mineral supplements in the preceding month (aged 17 y only), diabetes, and frequency of visits to the dentist or dental hygienist. In addition, female respondents were classified according to use of oral contraceptives, hormone replacement therapy, or both. Vitamin C intake was calculated from a 24-h dietary recall. Finally, body mass index (BMI) was calculated from measured height and weight.

Statistical analysis
We conducted a tooth-specific analysis with mesiobuccal sites as the unit of analysis. This approach allowed us to adjust for important site-specific covariates that are strong predictors of gingival bleeding (calculus and full crown coverage). To restrict the analysis to sites with marginal gingivitis, we excluded sites with clinical attachment loss > 2 mm (ie, bone loss resulting from periodontal disease). Furthermore, because smoking suppresses the bleeding response of the gingival tissues (18, 19), the analysis was restricted to subjects who reported to be never smokers and who had serum cotinine concentrations 15 ng/mL.

Descriptive statistics for covariates by quintiles of 25(OH)D concentrations were calculated with the subject as the unit of analysis. As suggested by a reviewer, P values for crude associations between covariates and 25(OH)D quintiles were calculated with the use of analysis of variance and chi-square statistics.

A multiple logistic regression model was fit to examine the association between gingival bleeding and serum concentrations of 25(OH)D . To account for the dependence of observations (sites) within subjects, generalized estimating equation marginal models with an exchangeable working correlation were used. Serum concentrations of 25(OH)D were categorized according to quintiles. In addition, 25(OH)D concentration was entered as a continuous variable to perform trend tests. The final model adjusted for age (continuous), sex, race-ethnicity (non-Hispanic whites, non-Hispanic blacks, Mexican Americans, other), poverty-to-income ratio (continuous), BMI (continuous), diabetes (yes or no), use of oral contraceptives or hormone replacement therapy among women (never, former, current, missing), intake of vitamin C (continuous), number of missing teeth (continuous), calculus (yes or no), full crown coverage (yes or no), and frequency of dental visits (less than once per year, at least once per year, missing). These variables were adjusted to account for known predictors of gingivitis (eg, calculus) and known modulators of gingivitis expression [eg, estrogens (20), diabetes (21, 22), intake of vitamin C (23)]. We further adjusted for dental examiner and survey phase (24).

Race or ethnicity, sex, and age were a priori considered as potentially important effect measure modifiers. We conducted formal tests of interaction by entering interaction terms in the model and also compared effect estimates from stratified analyses. We also compared effect estimates in supplement users and nonusers. Finally, deciles of 25(OH)D concentrations were entered into the main model to explore the dose-response relation more closely. All analyses were performed with the use of STATA 7.0 (Stata Corp, College Station, TX).


RESULTS  
There was a total of 6809 never smokers aged 13 to >90 years with 25(OH)D serum concentrations and periodontal data available with complete data on covariates. Of them, 109 subjects had no teeth with attachment loss 2 mm. Thus, the final sample consisted of 77 503 mesiobuccal sites (teeth) in 6700 subjects (2448 men and 4252 women). Women are overrepresented in this sample because of the restriction to never smokers.

Demographic characteristics of the sample and distribution of covariates by quintiles of serum concentrations of 25(OH)D are given in Table 1. Men, non-Hispanic whites, and current users of oral contraceptives or hormones among women had, on average, higher concentrations of 25(OH)D. Furthermore, subjects with higher serum concentrations of 25(OH)D were more likely to have higher incomes and to visit their dentist or dental hygienist more frequently. No significant interactions were observed with race-ethnicity, age, or sex, and effect estimates were similar across strata.


View this table:
TABLE 1. Demographic characteristics and distribution of covariates by quintiles of 25-hydroxyvitamin D [25(OH)D] serum concentration1

 
We found a strong negative association between serum concentrations of 25(OH)D and prevalence of bleeding on probing (Table 2). In the model controlling for age, sex, race-ethnicity, dental examiner, and survey phase, the odds ratio for bleeding for the highest (median: 99.6 nmol/L) compared with lowest (median: 32.4 nmol/L) 25(OH)D quintile was 0.74 (95% CI: 0.64, 0.86). Full adjustment for all other covariates resulted in an attenuation of the association. Compared with the lowest 25(OH)D quintile, sites in subjects in the highest 25(OH)D quintile had 20% (95% CI: 8%, 31%) lower odds of bleeding on probing. An increase in serum concentration of 25(OH)D of 30 nmol/L was associated with sites having 10% (95% CI: 5%, 14%) lower odds for bleeding. The association appeared to be linear over the entire 25(OH)D range (Figure 1). Finally, the odds ratio estimates were similar among users of multivitamin and mineral supplements and nonusers.


View this table:
TABLE 2. Odds ratios (ORs) and 95% CIs for prevalence of bleeding on probing by 25-hydroxyvitamin D [25(OH)D]

 

View larger version (17K):
FIGURE 1.. Odds ratios (ORs) and 95% CIs by deciles of serum concentrations of 25-hydroxyvitamin D [25(OH)D] (medians of deciles), adjusted for age, sex, race-ethnicity, income, BMI, intake of vitamin C, missing teeth, full crown coverage, calculus, frequency of dental visits, use of oral contraceptives and hormone replacement therapy among women, diabetes, and dental examiner and survey phase.

 

DISCUSSION  
In the present study, we found an inverse association between serum concentrations of 25(OH)D and chronic gingivitis as measured by bleeding on probing among participants who never smoked aged 13 to >90 y. The association was independent of age, sex, income, BMI, intake of vitamin C, full crown coverage, calculus, frequency of dental visits, diabetes, use of oral contraceptives and hormone replacement therapy among women, number of missing teeth, and diabetes. The association was consistent across racial or ethnic groups and appeared linear over the entire 25(OH)D range.

Considerable evidence is available for the antiinflammatory effects of vitamin D from in vitro studies. 1,25-(OH)2D3 has been shown to inhibit antigen-induced T cell proliferation and cytokine production, specifically interleukin 2 and interferon- (1, 2, 25, 26). Furthermore, vitamin D has marked effects on antigen-presenting cells (27-31). In addition, beneficial effects of 1,25-(OH)2D3 and its analogues have been shown in animal models of autoimmunity and transplantation. However, evidence from clinical human studies is scarce. In a cross-sectional study of 116 subjects, serum concentrations of 25(OH)D were negatively correlated with serum concentrations of C-reactive protein. In a subsample of 24 patients from that study, vitamin D supplementation significantly reduced serum concentrations of C-reactive protein by 23% (7). In a small randomized clinical trial of critically ill patients in the intensive care unit, supplementation with 500 IU parenteral vitamin D significantly decreased circulating concentrations of C-reactive protein (6).

No commonly accepted definition is available for "adequate" or "optimal" vitamin D status or 25(OH)D concentrations. Bone health has been the focus of efforts to define such optimal concentrations, usually based on the suppression of serum concentrations of parathyroid hormone as a surrogate marker, and the resulting recommendations vary widely (32-37). However, vitamin D likely has beneficial effects on various outcomes other than bone health, such as muscle strength (38-40), colon cancer (41, 42), and inflammatory diseases (3). In the present study, we did not find evidence for a threshold serum concentration of 25(OH)D, above which the association with gingival inflammation leveled off. Hence, the antiinflammatory effects of vitamin D may possibly extend to serum concentrations 90–100 nmol/L.

The present analysis was restricted to sites without any attachment or bone loss as a result of periodontitis. Therefore, the association found in this study is unrelated to any effects of vitamin D on bone. However, chronic marginal gingivitis may eventually lead to loss of alveolar bone and, thus, evolve into periodontal disease in susceptible patients. Because bone loss is pathognomonic for periodontal disease, studies have linked vitamin D status and polymorphisms of the vitamin D receptor genes to periodontal disease and tooth loss (8, 9, 43-46). In NHANES III, we have previously shown an inverse association between serum concentrations of 25(OH)D and prevalence of periodontal disease as measured by periodontal attachment loss (9). However, this association was independent of bone mineral density. The results of the present study are consistent with an antiinflammatory effect of vitamin D on gingival inflammation which may be an alternative pathway by which vitamin D may be beneficial for the prevention of periodontal disease.

The strength of the present study is its size. The size of the study allowed subgroup analyses and a site-specific analysis that accounted for site-specific covariates, which are important determinants of gingival inflammation.

The study has several limitations. The bacteria and bacterial products of dental plaque are the main cause of gingival inflammation. One important determinant of plaque levels is oral hygiene (ie, toothbrushing, flossing, etc), which, in turn, may be related to other health-conscious behaviors, including time spent outdoors. Plaque may, therefore, be an important confounder variable in the present study. Unfortunately, plaque levels were not measured in NHANES III; therefore, we could not adjust for dental plaque (ie, oral hygiene). However, we adjusted for calculus, which develops from dental plaque and is strongly correlated with it. As can be seen from Table 2, adjustment for calculus, frequency of dental visits, income, and other variables, including intake of vitamin C, result in a relatively minor attenuation of the odds ratio. It is, therefore, unlikely that the association reported here can be explained by a variation in plaque levels. However, we cannot rule out residual confounding by plaque levels.

Furthermore, this is a cross-sectional study, and a causal effect of 25(OH)D concentrations on gingival inflammation cannot be established on the basis of these data. However, the concomitant assessment of 25(OH)D concentrations and gingival inflammation is not likely to be an important problem, because gingival inflammation develops and resolves rapidly (11, 47). Intervention studies will be necessary to establish whether increased intake of vitamin D can reduce gingivitis susceptibility. We believe that marginal gingivitis may be a useful model to study the antiinflammatory effects of vitamin D in humans.

The results of the present study suggest that increased serum concentrations of vitamin D may be beneficial in regard to gingivitis susceptibility. This inverse association may be due to the antiinflammatory effect of vitamin D, which may be present in serum concentrations of 25(OH)D 90–100 nmol/L.


ACKNOWLEDGMENTS  
The analysis was planned by TD. TD conducted the analysis with contributions by MN. All authors evaluated the results and contributed to their interpretation. TD wrote the manuscript with input from all other authors. None of the authors had a conflict of interest.


REFERENCES  

  1. Bhalla AK, Amento EP, Serog B, Glimcher LH. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 1984;133:1748–54.
  2. Rigby WF, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 1987;79:1659–64.
  3. Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 2002;8:174–9.
  4. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60–5.
  5. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500–3.
  6. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003;88:4623–32.
  7. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? Q J Med 2002;95:787–96.
  8. Krall EA, Wehler C, Garcia RI, Harris SS, Dawson-Hughes B. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med 2001;111:452–6.
  9. Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr 2004;80:108–13.
  10. Loe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965;36:177–87.
  11. Trombelli L, Tatakis DN, Scapoli C, Bottega S, Orlandini E, Tosi M. Modulation of clinical expression of plaque-induced gingivitis. II. Identification of "high-responder" and "low-responder" subjects. J Clin Periodontol 2004;31:239–52.
  12. Drury TF, Winn DM, Snowden CB, Kingman A, Kleinman DV, Lewis B. An overview of the oral health component of the 1988–1991 National Health and Nutrition Examination Survey (NHANES III-Phase 1). J Dent Res 1996;75 Spec No:620–30.
  13. Albandar JM, Kingman A. Gingival recession, gingival bleeding, and dental calculus in adults 30 years of age and older in the United States, 1988–1994. J Periodontol 1999;70:30–43.
  14. Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000;71:743–51.
  15. Gunter EW, Lewis BL, Konkikowski SM. Laboratory methods used for the third National Health and Nutrition Examination Survey (NHANES II), 1988-1994 (CD-ROM). Hyattsville, MD: Centers for Disease Control and Prevention, 1996.
  16. Newbrun E. Indices to measure gingival bleeding. J Periodontol 1996;67:555–61.
  17. Brown LJ, Brunelle JA, Kingman A. Periodontal status in the United States, 1988–1991: prevalence, extent, and demographic variation. J Dent Res 1996;75 Spec No:672–83.
  18. Bergstrom J, Preber H. The influence of cigarette smoking on the development of experimental gingivitis. J Periodontal Res 1986;21:668–76.
  19. Dietrich T, Bernimoulin J-P, Glynn RJ. The effect of smoking on gingival bleeding. J Periodontol 2004;75:10–6.
  20. Sooriyamoorthy M, Gower DB. Hormonal influences on gingival tissue: relationship to periodontal disease. J Clin Periodontol 1989;16:201–8.
  21. Hugoson A, Thorstensson H, Falk H, Kuylenstierna J. Periodontal conditions in insulin-dependent diabetics. J Clin Periodontol 1989;16:215–23.
  22. Cutler CW, Machen RL, Jotwani R, Iacopino AM. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol 1999;70:1313–21.
  23. Leggott PJ, Robertson PB, Jacob RA, Zambon JJ, Walsh M, Armitage GC. Effects of ascorbic acid depletion and supplementation on periodontal health and subgingival microflora in humans. J Dent Res 1991;70:1531–6.
  24. Slade GD, Beck JD. Plausibility of periodontal disease estimates from NHANES III. J Public Health Dent 1999;59:67–72.
  25. Takeuchi A, Reddy GS, Kobayashi T, Okano T, Park J, Sharma S. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects. J Immunol 1998;160:209–18.
  26. Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995;15:5789–99.
  27. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000;164:4443–51.
  28. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000;164:2405–11.
  29. Griffin MD, Lutz WH, Phan VA, et al. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 2000;270:701–8.
  30. D'Ambrosio D, Cippitelli M, Cocciolo MG, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998;101:252–62.
  31. Berer A, Stockl J, Majdic O, et al. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000;28:575–83.
  32. Lips P, Wiersinga A, van Ginkel FC, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67:644–50.
  33. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805–6.
  34. Peacock M. Effects of calcium and vitamin D insufficiency on the skeleton. Osteoporos Int 1998;8:S45–51.
  35. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439–43.
  36. Dawson-Hughes B, Harris SS, Dallal GE. Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 1997;65:67–71.
  37. Krall EA, Sahyoun N, Tannenbaum S, Dallal GE, Dawson-Hughes B. Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 1989;321:1777–83.
  38. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986;7:434–47.
  39. Glerup H, Mikkelsen K, Poulsen L, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 2000;66:419–24.
  40. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88:5766–72.
  41. Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765–71.
  42. McCullough ML, Robertson AS, Rodriguez C, et al. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 2003;14:1–12.
  43. Yoshihara A, Sugita N, Yamamoto K, Kobayashi T, Miyazaki H, YoshiH. Analysis of vitamin D and Fcgamma receptor polymorphisms in Japanese patients with generalized early-onset periodontitis. J Dent Res 2001;80:2051–4.
  44. Hennig BJ, Parkhill JM, Chapple IL, Heasman PA, Taylor JJ. Association of a vitamin D receptor gene polymorphism with localized early-onset periodontal diseases. J Periodontol 1999;70:1032–8.
  45. Sun JL, Meng HX, Cao CF, et al. Relationship between vitamin D receptor gene polymorphism and periodontitis. J Periodontal Res 2002;37:263–7.
  46. Inagaki K, Krall EA, Fleet JC, Garcia RI. Vitamin D receptor alleles, periodontal disease progression, and tooth loss in the VA dental longitudinal study. J Dent Res 2003;74:161–7.
  47. Trombelli L, Scapoli C, Orlandini E, Tosi M, Bottega S, Tatakis DN. Modulation of clinical expression of plaque-induced gingivitis. III. Response of "high responders" and "low responders" to therapy. J Clin Periodontol 2004;31:253–9.
Received for publication January 27, 2005. Accepted for publication May 18, 2005.


作者: Thomas Dietrich
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具